Form 8-K - Current report:
SEC Accession No. 0000849146-21-000032
Filing Date
2021-02-02
Accepted
2021-02-02 16:08:06
Documents
18
Period of Report
2021-02-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20210201.htm   iXBRL 8-K 39318
2 EX-99.1 earningsrelease_q2fy21.htm EX-99.1 270133
3 EX-99.2 exhibit992pressrelease.htm EX-99.2 8544
9 image1a.jpg GRAPHIC 9719
10 logoa181a.jpg GRAPHIC 6462
  Complete submission text file 0000849146-21-000032.txt   511970

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20210201.xsd EX-101.SCH 2445
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20210201_cal.xml EX-101.CAL 728
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20210201_def.xml EX-101.DEF 1665
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20210201_lab.xml EX-101.LAB 25298
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20210201_pre.xml EX-101.PRE 13208
11 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20210201_htm.xml XML 11182
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 21581486
SIC: 2834 Pharmaceutical Preparations